GLAXOSMITHKLINE PHARMACEUTICALS
Back to Income Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹3,822 Cr | ₹3,749 Cr | ₹3,454 Cr | ₹3,252 Cr | ₹3,278 Cr |
What is the latest Revenue of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹3,822 Cr |
| Mar2025 | ₹3,749 Cr |
| Mar2024 | ₹3,454 Cr |
| Mar2023 | ₹3,252 Cr |
| Mar2022 | ₹3,278 Cr |
How is Revenue of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,822 Cr | 1.93 | |
| Mar2025 | ₹3,749 Cr | 8.56 | |
| Mar2024 | ₹3,454 Cr | 6.21 | |
| Mar2023 | ₹3,252 Cr | -0.80 | |
| Mar2022 | ₹3,278 Cr | - | |
Compare Revenue of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹43,024.2 Cr | -7.1% | -13.3% | -7.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,539.0 Cr | -1.4% | -6.6% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 1.2% | -2.6% | 60% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,251.0 Cr | -2% | -6.1% | 33% | Stock Analytics | |
| CIPLA | ₹105,290.0 Cr | -2.3% | -5.8% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,752.6 Cr | -1.1% | 3.8% | -5.5% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -7.1% |
-13.3% |
-7.3% |
| SENSEX | 0.8% |
-4.8% |
-10.5% |
You may also like the below Video Courses